This content is machine translated Gastrointestinal stromal tumors Portrait of a multifaceted disease With the introduction of the new active ingredient avapritinib for the targeted treatment of gastrointestinal stromal tumors into the German market, this clinical picture is once again coming more into…
View Post 8 min This content is machine translated Therapy for gastrointestinal stromal tumors Surgical and oncological aspects Before initiating therapy, GIST patients should be discussed at an interdisciplinary tumor board. For intermediate to high risk of relapse, adjuvant imatinib therapy should be considered after resection. Patients with…
